JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Endometrial Carcinoma G2 Origin: Derived from endometrial carcinoma Species: Homo sapiens Tissue: Uterus Morphology: Epithelial Properties: Adherent Cytogenic data: Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Derived from endometrial carcinoma Species: Homo sapiens Tissue: Uterus Morphology: Epithelial Properties: Adherent Cytogenic data: Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Homo sapiens Tissue: Uterus Morphology: Epithelial Properties: Adherent Cytogenic data: Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Uterus Morphology: Epithelial Properties: Adherent Cytogenic data: Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Epithelial Properties: Adherent Cytogenic data: Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Adherent Cytogenic data: Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Tumorigenic Patient: Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Female, Asian Medium: IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
IMDM + 10% FBS Subculture: 1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
1:2 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Hepatitis C: Negative Isoenzymes: G6PD(typeB), NP, LDH DNA Profile (STR): D5S818:10, 11, 12; D13S317:9, 10, 11; D7S820:10, 11, 14; D16S539:11, 12, 13; VWA:17, 20, 22; TH01:7, 9.3; Amelogenin:X; TPOX:11, 14; CSF1PO:9, 10 Mutations in HEC-59 Cells Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Mutations in HEC-59 Cells
HEC-59 cells
HeLa cells
SiHa cells
CaSKi cells
C33A cells
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
C0026001.pdf
Request safety datasheet
Delivery expected until 7/31/2025
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!